BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yan LN, Zhang X, Xu F, Fan YY, Ge B, Guo H, Li ZL. Four-microRNA signature for detection of type 2 diabetes. World J Clin Cases 2020; 8(10): 1923-1931 [PMID: 32518782 DOI: 10.12998/wjcc.v8.i10.1923]
URL: https://www.wjgnet.com/2307-8960/full/v8/i10/1923.htm
Number Citing Articles
1
Kanika Suri, Jason A. Bubier, Michael V. Wiles, Leonard D. Shultz, Mansoor M. Amiji, Vishnu Hosur. Role of MicroRNA in Inflammatory Bowel Disease: Clinical Evidence and the Development of Preclinical Animal ModelsCells 2021; 10(9): 2204 doi: 10.3390/cells10092204
2
María Victoria Mencucci, Ana María Rojas-Mendoza, Eduardo Andrés-León, Carolina Lisi Román, Juan José Gagliardino, Martín Carlos Abba, Bárbara Maiztegui. Identification of novel microRNAs associated with type 2 diabetes by an integrative bioinformatic analysisHuman Gene 2022; 34: 201125 doi: 10.1016/j.humgen.2022.201125
3
Ilhaam Ayaz Durrani, Attya Bhatti, Peter John. Regulatory MicroRNAs in T2DM and Breast CancerProcesses 2021; 9(5): 819 doi: 10.3390/pr9050819
4
Mohammad Reza Afsharmanesh, Zeinab Mohammadi, Azad Reza Mansourian, Seyyed Mehdi Jafari. A Review of micro RNAs changes in T2DM in animals and humansJournal of Diabetes 2023; 15(8): 649 doi: 10.1111/1753-0407.13431
5
Ya-Ke Lu, Xi Chu, Shuo Wang, Yue Sun, Jie Zhang, Jing Dong, Yu-Xiang Yan. Identification of Circulating hsa_circ_0063425 and hsa_circ_0056891 as Novel Biomarkers for Detection of Type 2 DiabetesThe Journal of Clinical Endocrinology & Metabolism 2021; 106(7): e2688 doi: 10.1210/clinem/dgab101
6
Felipe Padilla-Martinez, Gladys Wojciechowska, Lukasz Szczerbinski, Adam Kretowski. Circulating Nucleic Acid-Based Biomarkers of Type 2 DiabetesInternational Journal of Molecular Sciences 2021; 23(1): 295 doi: 10.3390/ijms23010295
7
Weronika Kraczkowska, Lucyna Stachowiak, Andrzej Pławski, Paweł Piotr Jagodziński. Circulating miRNA as potential biomarkers for diabetes mellitus type 2: should we focus on searching for sex differences?Journal of Applied Genetics 2022; 63(2): 293 doi: 10.1007/s13353-021-00678-5
8
Bartosz Walkowski, Marcin Kleibert, Miłosz Majka, Małgorzata Wojciechowska. Insight into the Role of the PI3K/Akt Pathway in Ischemic Injury and Post-Infarct Left Ventricular Remodeling in Normal and Diabetic HeartCells 2022; 11(9): 1553 doi: 10.3390/cells11091553
9
Angel Mendonca, Prabu Thandapani, Priyashree Nagarajan, Sanjana Venkatesh, Sujatha Sundaresan. Role of microRNAs in regulation of insulin secretion and insulin signaling involved in type 2 diabetes mellitusJournal of Biosciences 2022; 47(4) doi: 10.1007/s12038-022-00295-2
10
Manjusha Sita Akella, Angel Mendonca, Thanikes Manikandan, Dhananjay Sateesh, Akshitha Rajesh Swaminathan, Disha Parameshwaran, Manishika Gupta, Sujatha Sundaresan. A compendium of noncoding RNAs as biomarkers in Type 2 Diabetes MellitusJournal of Pharmaceutical and Biomedical Analysis Open 2025; 5: 100057 doi: 10.1016/j.jpbao.2025.100057
11
Mohammad Muzaffar Mir, Mushabab Alghamdi, Waad Fuad BinAfif, Muffarah Hamid Alharthi, Abdullah M. Alshahrani, Mohannad Mohammad S. Alamri, Jaber Alfaifi, Ahmed Yahia Al Ameer, Rashid Mir. Advances in Clinical Chemistry 2025;  doi: 10.1016/bs.acc.2025.01.002
12
Elnaz Ghoreishi, Seyedeh Zahra Shahrokhi, Faranak Kazerouni, Ali Rahimipour. Circulating miR-148b-3p and miR-27a-3p can be potential biomarkers for diagnosis of pre-diabetes and type 2 diabetes: integrating experimental and in-silico approachesBMC Endocrine Disorders 2022; 22(1) doi: 10.1186/s12902-022-01120-5
13
Chioma Odimegwu, Samuel Uwaezuoke, Ugo Chikani, Ngozi Mbanefo, Ken Adiele, Charles Nwolisa, Chizoma Eneh, Chibuzo Ndiokwelu, Somkenechi Okpala, Francis Ogbuka, Kenneth Odo, Ijeoma Ohuche, Chinelo Obiora-Izuka. Targeting the Epigenetic Marks in Type 2 Diabetes Mellitus: Will Epigenetic Therapy Be a Valuable Adjunct to Pharmacotherapy?Diabetes, Metabolic Syndrome and Obesity 2024; : 3557 doi: 10.2147/DMSO.S479077
14
Miłosz Majka, Marcin Kleibert, Małgorzata Wojciechowska. Impact of the Main Cardiovascular Risk Factors on Plasma Extracellular Vesicles and Their Influence on the Heart’s Vulnerability to Ischemia-Reperfusion InjuryCells 2021; 10(12): 3331 doi: 10.3390/cells10123331
15
Khaoula Errafii, Amin Jayyous, Abdelillah Arredouani, Hasan Khatib, Fouad Azizi, Ramzi M. Mohammad, Muhammad Abdul-Ghani, Mohamed Chikri. Comprehensive analysis of circulating miRNA expression profiles in insulin resistance and type 2 diabetes in Qatari populationAll Life 2022; 15(1): 191 doi: 10.1080/26895293.2022.2033853
16
Guang Yang, Jinxin Shi. miRNA-130a-3p targets sphingosine-1-phosphate receptor 1 to activate the microglial and astrocytes and to promote neural injury under the high glucose conditionOpen Medicine 2022; 17(1): 2117 doi: 10.1515/med-2022-0565
17
Joanna Szydełko, Beata Matyjaszek-Matuszek. MicroRNAs as Biomarkers for Coronary Artery Disease Related to Type 2 Diabetes Mellitus—From Pathogenesis to Potential Clinical ApplicationInternational Journal of Molecular Sciences 2022; 24(1): 616 doi: 10.3390/ijms24010616
18
Hsiuying Wang. MicroRNAs, Parkinson’s Disease, and Diabetes MellitusInternational Journal of Molecular Sciences 2021; 22(6): 2953 doi: 10.3390/ijms22062953
19
Constantine E Kosmas, Andreas Sourlas, Konstantinos Oikonomakis, Eleni-Angeliki Zoumi, Aikaterini Papadimitriou, Christina E Kostara. Biomarkers of insulin sensitivity/resistanceJournal of International Medical Research 2024; 52(10) doi: 10.1177/03000605241285550
20
Marianna ABATE, Amalia LUCE, Alessia M. COSSU, Marianna SCRIMA, Gabriella MISSO, Michele CARAGLIA, Silvia ZAPPAVIGNA. Molecular markers as a new tool for diagnostic and prognostic definition of type 2 diabetes mellitusMinerva Medica 2023; 113(6) doi: 10.23736/S0026-4806.22.08315-X